Approval · Notice of Compliance 3485 · 2003
UNITRON PEG: Notice of Compliance 3485
Issued January 10, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3485
- Date
- January 10, 2003
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change from peg-intron
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| UNITRON PEG | 02242966 | Cancelled Post Market |
| UNITRON PEG | 02242967 | Cancelled Post Market |
| UNITRON PEG | 02242968 | Cancelled Post Market |
| UNITRON PEG | 02242969 | Cancelled Post Market |
Medicinal ingredients
- PEGINTERFERON ALFA-2B 74 MCG per VIAL
- PEGINTERFERON ALFA-2B 118.4 MCG per VIAL
- PEGINTERFERON ALFA-2B 177.6 MCG per VIAL
- PEGINTERFERON ALFA-2B 222 MCG per VIAL